Steris (NYSE:STE) has been analyzed by 4 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish. The table below offers a condensed view of their recent ratings, showcasing the changing sentiments over the past 30 days and comparing them to the preceding months. Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $263.75, along with a high estimate of $265.00 and a low estimate of $260.00. This upward trend is evident, with the current average reflecting a 0.96% increase from the previous ave…